Clarivate provides subscription data, analytics and workflow software used across scientific research, intellectual property and life sciences. Flagship assets include Web of Science for scholarly citation indexing, Derwent for patent intelligence and Cortellis for drug development intelligence. Customers range from universities and research libraries to pharma R&D teams and IP professionals who rely on structured, curated content rather than raw web search.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 621.4 | — | -72 | — |
| Q3 2025 | 623.1 | — | -28.3 | — |
| Q4 2025 | 617 | — | 3.1 | — |
| Q1 2026 | 585.5 | — | -40.2 | — |
| Q2 2026 | 587.3 | -5.5% | -268.6 | — |
All markets — KeepWinning global stock screener
Other companies on NYSE: T1 Energy Inc. (TE), Orchid Island Capital, Inc. (ORC), Dole plc (DOLE), Gold.com, Inc. (GOLD), Ryerson Holding Corporation (RYZ), Two Harbors Investment Corp. (TWO)